{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T15:01:22Z","timestamp":1769526082124,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Optic nerve astrocytomas (ONAs) are neurological neoplasms in the central nervous system (CNS), and they have the highest incidence rate among all the tumor types in the visual pathway. In this study, we conducted a Surveillance, Epidemiology, and End Results (SEER) -based research to explore the demographic, survival, and prognostic factors of patients diagnosed with ONAs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Utilizing the SEER database, we retrospectively evaluated data of patients diagnosed with ONAs of all ages from 1984 to 2016. We used the Student\u2019s t distribution to test variables of patients and various characteristics, and Kaplan-Meier curve to illustrate overall survival (OS) with 95.0% confidence intervals (CIs). We also performed univariate and multivariate analyses to evaluate various variables\u2019 validity on overall survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 1004 cases were analyzed, and revealed that age (P&lt;0.001, hazard ratio (HR)\u2009=\u20098.830, 95% CI: 4.088\u201319.073), tumor grade (P&lt;0.001, HR\u2009=\u20091.927, 95% CI: 1.516\u20132.450), diagnostic confirmation (P&lt;0.001, HR\u2009=\u20092.444, 95% CI: 1.632\u20133.660), and histology type (<jats:italic>P<\/jats:italic>\u2009=\u20090.046, HR\u2009=\u20091.563, 95% CI: 1.008\u20132.424) of the tumor were associated with decreased survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>From this large, comparative study of ONAs, we found that younger age may be considered as a protective indicator, while high-grade astrocytic tumors have a worse prognosis. We also found that diagnostic confirmation and tumor grade were independent prognostic factors in this patient population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08719-2","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T15:03:53Z","timestamp":1630335833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Demographic and prognostic factors of optic nerve astrocytoma: a retrospective study of surveillance, epidemiology, and end results (SEER)"],"prefix":"10.1186","volume":"21","author":[{"given":"Mingui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yisheng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,30]]},"reference":[{"issue":"2","key":"8719_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF00307925","volume":"6","author":"V Benes","year":"1990","unstructured":"Benes V, Julisova I, Julis I. Our treatment philosophy of gliomas of the anterior visual pathways. Childs Nerv Syst. 1990;6(2):75\u20138. https:\/\/doi.org\/10.1007\/BF00307925.","journal-title":"Childs Nerv Syst"},{"issue":"12","key":"8719_CR2","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.ejca.2006.02.022","volume":"42","author":"E Opocher","year":"2006","unstructured":"Opocher E, Kremer LC, Da Dalt L, Wetering MD, Viscardi E, Caron HN, et al. Prognostic factors for progression of childhood optic pathway glioma: a systematic review. Eur J Cancer. 2006;42(12):1807\u201316.","journal-title":"Eur J Cancer"},{"issue":"Suppl 5","key":"8719_CR3","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","volume":"21","author":"QT Ostrom","year":"2019","unstructured":"Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016. Neuro-Oncology. 2019;21(Suppl 5):v1\u2013v100. https:\/\/doi.org\/10.1093\/neuonc\/noz150.","journal-title":"Neuro-Oncology"},{"issue":"4","key":"8719_CR4","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1159\/000448006","volume":"2","author":"HS Mudhar","year":"2016","unstructured":"Mudhar HS, Nuruddin M, Roy S. Primary orbital cystic Pilocytic astrocytoma. Ocul Oncol Pathol. 2016;2(4):280\u20134. https:\/\/doi.org\/10.1159\/000448006.","journal-title":"Ocul Oncol Pathol"},{"key":"8719_CR5","first-page":"4283570","volume":"2017","author":"I Apanisile","year":"2017","unstructured":"Apanisile I, Karosi T. Surgical Management of Pilocytic Astrocytoma of the optic nerve: a case report and review of the literature. Case Rep Oncol Med. 2017;2017:4283570.","journal-title":"Case Rep Oncol Med"},{"issue":"2","key":"8719_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97\u2013109. https:\/\/doi.org\/10.1007\/s00401-007-0243-4.","journal-title":"Acta Neuropathol"},{"issue":"10","key":"8719_CR7","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/modpathol.2013.79","volume":"26","author":"GF Reis","year":"2013","unstructured":"Reis GF, Bloomer MM, Perry A. Joanna J Phillips, James P Grenert, Anthony N Karnezis and Tarik Tihan: Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system. Mod Pathol. 2013;26(10):1279\u201387. https:\/\/doi.org\/10.1038\/modpathol.2013.79.","journal-title":"Mod Pathol"},{"issue":"3","key":"8719_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/BF02893364","volume":"12","author":"A Malik","year":"2006","unstructured":"Malik A, Deb P, Sharma MC, Sarkar C. Neuropathological spectrum of pilocytic astrocytoma: an Indian series of 120 cases. Pathol Oncol Res. 2006;12(3):164\u201371. https:\/\/doi.org\/10.1007\/BF02893364.","journal-title":"Pathol Oncol Res"},{"issue":"5","key":"8719_CR9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1080\/00207454.2018.1538989","volume":"129","author":"MJ Al-Husseini","year":"2019","unstructured":"Al-Husseini MJ, Saad AM, El-Shewy KM, Nissan NE, Gad MM, Alzuabi MA, et al. Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study. Int J Neurosci. 2019;129(5):447\u201354. https:\/\/doi.org\/10.1080\/00207454.2018.1538989.","journal-title":"Int J Neurosci"},{"issue":"5","key":"8719_CR10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/ICU.0000000000000587","volume":"30","author":"MK Farazdaghi","year":"2019","unstructured":"Farazdaghi MK, Katowitz WR, Avery RA. Current treatment of optic nerve gliomas. Curr Opin Ophthalmol. 2019;30(5):356\u201363. https:\/\/doi.org\/10.1097\/ICU.0000000000000587.","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"8719_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U","volume":"70","author":"JM Friedman","year":"1997","unstructured":"Friedman JM, Birch PH. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet. 1997;70(2):138\u201343. https:\/\/doi.org\/10.1002\/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U.","journal-title":"Am J Med Genet"},{"key":"8719_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.critrevonc.2016.05.008","volume":"104","author":"J Helfferich","year":"2016","unstructured":"Helfferich J, Nijmeijer R, Brouwer OF, Boon M, Fock A, Hoving EW, et al. Neurofibromatosis type 1 associated low grade gliomas: a comparison with sporadic low grade gliomas. Crit Rev Oncol Hematol. 2016;104:30\u201341. https:\/\/doi.org\/10.1016\/j.critrevonc.2016.05.008.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"8719_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/ajmg.a.20211","volume":"122a","author":"A King","year":"2003","unstructured":"King A, Listernick R, Charrow J, Piersall L, Gutmann DH. Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome. Am J Med Genet A. 2003;122a(2):95\u20139.","journal-title":"Am J Med Genet A"},{"key":"8719_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.canep.2018.04.005","volume":"54","author":"EC Peckham-Gregory","year":"2018","unstructured":"Peckham-Gregory EC, Montenegro RE, Stevenson DA, Viskochil DH, Scheurer ME, Lupo PJ, et al. Evaluation of racial disparities in pediatric optic pathway glioma incidence: results from the surveillance, epidemiology, and end results program, 2000-2014. Cancer Epidemiol. 2018;54:90\u20134. https:\/\/doi.org\/10.1016\/j.canep.2018.04.005.","journal-title":"Cancer Epidemiol"},{"issue":"12","key":"8719_CR15","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.jocn.2011.09.003","volume":"18","author":"J Shapey","year":"2011","unstructured":"Shapey J, Danesh-Meyer HV, Kaye AH. Diagnosis and management of optic nerve glioma. J Clin Neurosci. 2011;18(12):1585\u201391. https:\/\/doi.org\/10.1016\/j.jocn.2011.09.003.","journal-title":"J Clin Neurosci"},{"issue":"7","key":"8719_CR16","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/pbc.22198","volume":"53","author":"G Nicolin","year":"2009","unstructured":"Nicolin G, Parkin P, Mabbott D, Hargrave D, Bartels U, Tabori U, et al. Natural history and outcome of optic pathway gliomas in children. Pediatr Blood Cancer. 2009;53(7):1231\u20137. https:\/\/doi.org\/10.1002\/pbc.22198.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"8719_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000445064","volume":"51","author":"A Ertiaei","year":"2016","unstructured":"Ertiaei A, Hanaei S, Habibi Z, Moradi E, Nejat F. Optic pathway gliomas: clinical manifestation, treatment, and follow-up. Pediatr Neurosurg. 2016;51(5):223\u20138. https:\/\/doi.org\/10.1159\/000445064.","journal-title":"Pediatr Neurosurg"},{"issue":"2","key":"8719_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/pbc.24726","volume":"61","author":"E Kalin-Hajdu","year":"2014","unstructured":"Kalin-Hajdu E, Decarie JC, Marzouki M, Carret AS, Ospina LH. Visual acuity of children treated with chemotherapy for optic pathway gliomas. Pediatr Blood Cancer. 2014;61(2):223\u20137. https:\/\/doi.org\/10.1002\/pbc.24726.","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"8719_CR19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1136\/bjo.53.12.793","volume":"53","author":"WF Hoyt","year":"1969","unstructured":"Hoyt WF, Baghdassarian SA. Optic glioma of childhood. Natural history and rationale for conservative management. Br J Ophthalmol. 1969;53(12):793\u20138.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"8719_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3171\/jns.1988.68.1.0085","volume":"68","author":"EC Alvord Jr","year":"1988","unstructured":"Alvord EC Jr, Lofton S. Gliomas of the optic nerve or chiasm. Outcome by patients' age, tumor site, and treatment. J Neurosurg. 1988;68(1):85\u201398.","journal-title":"J Neurosurg"},{"issue":"5","key":"8719_CR21","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/pbc.20655","volume":"46","author":"CD Jahraus","year":"2006","unstructured":"Jahraus CD, Tarbell NJ. Optic pathway gliomas. Pediatr Blood Cancer. 2006;46(5):586\u201396. https:\/\/doi.org\/10.1002\/pbc.20655.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"8719_CR22","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/archopht.119.4.516","volume":"119","author":"CF Parsa","year":"2001","unstructured":"Parsa CF, Hoyt CS, Lesser RL, Weinstein JM, Strother CM, Muci-Mendoza R, et al. Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging. Arch Ophthalmol. 2001;119(4):516\u201329. https:\/\/doi.org\/10.1001\/archopht.119.4.516.","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"8719_CR23","first-page":"1134","volume":"98","author":"G Yoshikawa","year":"2003","unstructured":"Yoshikawa G, Nagata K, Kawamoto S, Tsutsumi K. Remarkable regression of optic glioma in an infant. Case illustration J Neurosurg. 2003;98(5):1134.","journal-title":"Case illustration J Neurosurg"},{"issue":"3","key":"8719_CR24","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.ijrobp.2004.12.081","volume":"62","author":"SE Combs","year":"2005","unstructured":"Combs SE, Schulz-Ertner D, Moschos D, Thilmann C, Huber PE, Debus J. Fractionated stereotactic radiotherapy of optic pathway gliomas: tolerance and long-term outcome. Int J Radiat Oncol Biol Phys. 2005;62(3):814\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.12.081.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3S Suppl 1","key":"8719_CR25","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1097\/IOP.0000000000000687","volume":"33","author":"KE Revere","year":"2017","unstructured":"Revere KE, Katowitz WR, Katowitz JA, Rorke-Adams L, Fisher MJ, Liu GT. Childhood Optic Nerve Glioma: Vision Loss Due to Biopsy. Ophthalmic Plast Reconstr Surg. 2017;33(3S Suppl 1):S107\u2013s109.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"3","key":"8719_CR26","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s11060-011-0783-2","volume":"107","author":"MV Mishra","year":"2012","unstructured":"Mishra MV, Andrews DW, Glass J, Evans JJ, Dicker AP, Shen X, et al. Characterization and outcomes of optic nerve gliomas: a population-based analysis. J Neuro-Oncol. 2012;107(3):591\u20137. https:\/\/doi.org\/10.1007\/s11060-011-0783-2.","journal-title":"J Neuro-Oncol"},{"issue":"6","key":"8719_CR27","doi-asserted-by":"publisher","first-page":"e0127676","DOI":"10.1371\/journal.pone.0127676","volume":"10","author":"J Rakotonjanahary","year":"2015","unstructured":"Rakotonjanahary J, Carli ED, Delion M, Kalifa C, Grill J, Doz F, et al. Rialland X and brain tumor committee of SFCE: mortality in children with optic pathway glioma treated with up-front BB-SFOP chemotherapy. PLoS One. 2015;10(6):e0127676. https:\/\/doi.org\/10.1371\/journal.pone.0127676.","journal-title":"PLoS One"},{"issue":"1","key":"8719_CR28","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1186\/s12885-018-4610-4","volume":"18","author":"AM Saad","year":"2018","unstructured":"Saad AM, Turk T, Al-Husseini MJ, Abdel-Rahman O. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study. BMC Cancer. 2018;18(1):688. https:\/\/doi.org\/10.1186\/s12885-018-4610-4.","journal-title":"BMC Cancer"},{"key":"8719_CR29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jns.2019.03.028","volume":"400","author":"MA Tabash","year":"2019","unstructured":"Tabash MA. Characteristics, survival and incidence rates and trends of pilocytic astrocytoma in children in the United States; SEER-based analysis. J Neurol Sci. 2019;400:148\u201352. https:\/\/doi.org\/10.1016\/j.jns.2019.03.028.","journal-title":"J Neurol Sci"},{"issue":"2","key":"8719_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.17849\/insm-47-02-65-94.1","volume":"47","author":"AF Milano","year":"2017","unstructured":"Milano AF, Singer RB. The Cancer mortality risk project - Cancer mortality risks by anatomic site: part 1 - introductory overview; part II - carcinoma of the Colon: 20-year mortality follow-up derived from 1973-2013 (NCI) SEER*stat survival database. J Insur Med. 2017;47(2):65\u201394. https:\/\/doi.org\/10.17849\/insm-47-02-65-94.1.","journal-title":"J Insur Med"},{"key":"8719_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jocn.2018.11.025","volume":"61","author":"D Diaz-Aguilar","year":"2019","unstructured":"Diaz-Aguilar D, ReFaey K, Clifton W, Durcanova B, Chen SG, Deen HG, et al. Prognostic factors and survival in low grade gliomas of the spinal cord: a population-based analysis from 2006 to 2012. J Clin Neurosci. 2019;61:14\u201321. https:\/\/doi.org\/10.1016\/j.jocn.2018.11.025.","journal-title":"J Clin Neurosci"},{"issue":"5","key":"8719_CR32","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00381-012-1705-0","volume":"28","author":"C Ononiwu","year":"2012","unstructured":"Ononiwu C, Mehta V, Bettegowda C, Jallo G. Pediatric spinal glioblastoma multiforme: current treatment strategies and possible predictors of survival. Childs Nerv Syst. 2012;28(5):715\u201320. https:\/\/doi.org\/10.1007\/s00381-012-1705-0.","journal-title":"Childs Nerv Syst"},{"issue":"1\u20132","key":"8719_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-510X(01)00538-X","volume":"188","author":"JL Winters","year":"2001","unstructured":"Winters JL, Wilson D, Davis DG. Congenital glioblastoma multiforme: a report of three cases and a review of the literature. J Neurol Sci. 2001;188(1\u20132):13\u20139. https:\/\/doi.org\/10.1016\/S0022-510X(01)00538-X.","journal-title":"J Neurol Sci"},{"issue":"1","key":"8719_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11060-011-0718-y","volume":"107","author":"B Wolff","year":"2012","unstructured":"Wolff B, Ng A, Roth D, Parthey K, Warmuth-Metz M, Eyrich M, et al. Pediatric high grade glioma of the spinal cord: results of the HIT-GBM database. J Neuro-Oncol. 2012;107(1):139\u201346. https:\/\/doi.org\/10.1007\/s11060-011-0718-y.","journal-title":"J Neuro-Oncol"},{"issue":"3","key":"8719_CR35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/cncr.11534","volume":"98","author":"JS Barnholtz-Sloan","year":"2003","unstructured":"Barnholtz-Sloan JS, Sloan AE, Schwartz AG. Racial differences in survival after diagnosis with primary malignant brain tumor. Cancer. 2003;98(3):603\u20139. https:\/\/doi.org\/10.1002\/cncr.11534.","journal-title":"Cancer"},{"key":"8719_CR36","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.12659\/MSM.890762","volume":"20","author":"A Gabriel","year":"2014","unstructured":"Gabriel A, Batey J, Capogreco J, Kimball D, Walters A, Tubbs RS, et al. Adult brain cancer in the U.S. black population: a surveillance, epidemiology, and end results (SEER) analysis of incidence, survival, and trends. Med Sci Monit. 2014;20:1510\u20137. https:\/\/doi.org\/10.12659\/MSM.890762.","journal-title":"Med Sci Monit"},{"issue":"1","key":"8719_CR37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.neucir.2017.08.003","volume":"29","author":"LH Gonzalez-Quarante","year":"2018","unstructured":"Gonzalez-Quarante LH, Ruiz-Juretschke F, Sola Vendrell E, Corral OL, Agarwal V, Garcia-Leal R. Multinodular and vacuolating neuronal tumor of the cerebrum. A rare entity. New case and review of the literature. Neurocirugia (Astur). 2018;29(1):44\u201355.","journal-title":"Neurocirugia (Astur)"},{"issue":"3","key":"8719_CR38","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/WNO.0b013e31822aef82","volume":"31","author":"RA Avery","year":"2011","unstructured":"Avery RA, Fisher MJ, Liu GT. Optic pathway gliomas. J Neuroophthalmol. 2011;31(3):269\u201378. https:\/\/doi.org\/10.1097\/WNO.0b013e31822aef82.","journal-title":"J Neuroophthalmol"},{"issue":"2","key":"8719_CR39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11060-010-0159-z","volume":"100","author":"P Hernaiz Driever","year":"2010","unstructured":"Hernaiz Driever P, Hornstein S, Pietsch T, Kortmann R, Warmuth-Metz M, Emser A, et al. Natural history and management of low-grade glioma in NF-1 children. J Neuro-Oncol. 2010;100(2):199\u2013207. https:\/\/doi.org\/10.1007\/s11060-010-0159-z.","journal-title":"J Neuro-Oncol"},{"issue":"4","key":"8719_CR40","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0887-8994(02)00628-8","volume":"28","author":"SL Tow","year":"2003","unstructured":"Tow SL, Chandela S, Miller NR, Avellino AM. Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr Neurol. 2003;28(4):262\u201370. https:\/\/doi.org\/10.1016\/S0887-8994(02)00628-8.","journal-title":"Pediatr Neurol"},{"issue":"4","key":"8719_CR41","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/cncr.11119","volume":"97","author":"M Fouladi","year":"2003","unstructured":"Fouladi M, Wallace D, Langston JW, Mulhern R, Rose SR, Gajjar A, et al. Survival and functional outcome of children with hypothalamic\/chiasmatic tumors. Cancer. 2003;97(4):1084\u201392. https:\/\/doi.org\/10.1002\/cncr.11119.","journal-title":"Cancer"},{"issue":"2","key":"8719_CR42","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3171\/jns.1998.88.2.0215","volume":"88","author":"JC Allen","year":"1998","unstructured":"Allen JC, Aviner S, Yates AJ, Boyett JM, Cherlow JM, Turski PA, et al. Treatment of high-grade spinal cord astrocytoma of childhood with \"8-in-1\" chemotherapy and radiotherapy: a pilot study of CCG-945. Children's Cancer Group. J Neurosurg. 1998;88(2):215\u201320. https:\/\/doi.org\/10.3171\/jns.1998.88.2.0215.","journal-title":"J Neurosurg"},{"issue":"4","key":"8719_CR43","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/02688690903121807","volume":"23","author":"BL Pizer","year":"2009","unstructured":"Pizer BL, Clifford SC. The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials. Br J Neurosurg. 2009;23(4):364\u201375. https:\/\/doi.org\/10.1080\/02688690903121807.","journal-title":"Br J Neurosurg"},{"issue":"3","key":"8719_CR44","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3171\/jns.1995.83.3.0480","volume":"83","author":"G Cinalli","year":"1995","unstructured":"Cinalli G, Sainte-Rose C, Lellouch-Tubiana A, Sebag G, Renier D, Pierre-Kahn A. Hydrocephalus associated with intramedullary low-grade glioma. Illustrative cases and review of the literature. J Neurosurg. 1995;83(3):480\u20135.","journal-title":"J Neurosurg"},{"issue":"7","key":"8719_CR45","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s00381-015-2670-1","volume":"31","author":"A Arnautovic","year":"2015","unstructured":"Arnautovic A, Billups C, Broniscer A, Gajjar A, Boop F, Qaddoumi I. Delayed diagnosis of childhood low-grade glioma: causes, consequences, and potential solutions. Childs Nerv Syst. 2015;31(7):1067\u201377. https:\/\/doi.org\/10.1007\/s00381-015-2670-1.","journal-title":"Childs Nerv Syst"},{"issue":"Suppl 4","key":"8719_CR46","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nou223","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007\u20132011. Neuro Oncol. 2014;16(Suppl 4):iv1\u201363.","journal-title":"Neuro Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08719-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08719-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08719-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T15:05:40Z","timestamp":1630335940000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08719-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8719"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08719-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,30]]},"assertion":[{"value":"5 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The informed consent was waived by Research Ethics Committee of Ruijin Hospital Affiliated to Shanghai Jiaotong University. IRB approval was exempt by the institutional review board of Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"976"}}